Benjamin Hohl

Affiliations

  • Chief Financial Officer at Enliven Therapeutics Inc. (ELVN), 2024-04-15
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ELVN $25.04 10,223 0 2024-04-11 Filing
ELVN $23.88 3,777 10,223 2024-04-11 Filing
ELVN $18.72 182 0 2024-03-27 Filing
ELVN $18.22 3,068 182 2024-03-27 Filing
ELVN $16.97 3,250 0 2024-02-27 Filing